天士力：获得温经汤颗粒药品注册证书

Core Viewpoint - Tianshili (600535) has received a drug registration certificate from the National Medical Products Administration for its product, Wengjing Decoction Granules, which is indicated for treating specific gynecological conditions [1] Company Summary - Tianshili announced the receipt of the drug registration certificate on October 13 [1] - The product, Wengjing Decoction Granules, is designed to supplement and warm the body, alleviate pain, and is used for conditions related to blood deficiency and stagnation [1] - The specific symptoms addressed by the product include menstrual irregularities and abdominal pain in women [1]